NCDRC Slaps Rs 16 Lakh Compensation on Maha Hospital for Negligence leading to minor’s death

New Delhi: The National Consumer Disputes Redressal Commission (NCDRC) recently held a Thane-based Hospital liable for medical negligence while providing treatment to a minor patient, who died after developing acute renal failure.

Accordingly, the Apex Consumer Court directed the Tarapur Atomic Power Station Hospital to pay Rs 16 lakh as compensation and Rs 1 lakh as litigation cost to the parents of the deceased patient.

While considering the complaint, the NCDRC bench opined that the hospital was responsible for the patient’s death for not taking into cognizance the reduced urine output on the date on which it was first reported and for not referring the patient to a Super Specialty Hospital soon after it came to know of the reduced urine output in the circumstances of the case.

The history of the case goes back to 1998 when the complainant couple’s son was suffering from a high fever and was admitted to TAPS Hospital, under the C.H.S facility. Accordingly, the duty doctor checked the patient, and blood and urine samples were taken for investigation.

It was alleged that noticing that there was no improvement in the patient’s condition, the complainants started requesting the treating doctor at the hospital as well as the Hospital Superintendent to refer the patient to BARC Trombay Hospital. However, the requests were refused, even though the patient was struggling for life.

After conducting the Sonoraphy test and noting that the patient had started becoming weak, Dr. Vachcharajani referred the patient on 16.07.1998 to BARC Hospital. On the same day at 4 pm, the complainants admitted the patient to BARC Trombay Hospital, where, after examining the patient, the doctors found that the kidneys of the patient had stopped functioning and there was an acute respiratory problem. However, due to the non-availability of the facilities, the patient was referred to Jaslok Hospital for specialized treatment. On the same day i.e. 16.07.1998 at around 7.30 pm, the Complainants shifted the patient to Jaslok Hospital, where at about 6.10 am on 17.07.1998, the patient ultimately died.

Alleging gross medical negligence resulting in the death of their only son, the Complainants filed a complaint before the State Commission seeking a compensation of Rs 16 lakh with interest at the rate of 18% p.a. from the date of filing of the complaint.

On the other hand, the TAPS Hospital and its doctors denied the allegations of negligence levelled against them during the patient’s treatment. They submitted that the patient was admitted to the Hospital with high-grade fever and body ache and a standard line of treatment was adopted. The patient was attended to by various qualified doctors, who treated the patient with all due required steps till the discharge of the patient from the Hospital on 16.07.1998.

They claimed that necessary blood tests, pathological tests etc. were advised and done and X-ray reports and pathological reports were found to be normal. Consequently, urgent investigations concerning the patient’s condition were advised, and the reports of which suggested acute renal failure and impending Septicaemia. Due to this, it was decided to refer the patient to BARC Hospital, Mumbai.

The State Commission dismissed the complaint and following this, challenging the order, the complainants approached the Apex Consumer Court. The Appellant’s counsel cited expert opinion of Dr Seth, which showed a deficiency on the part of the hospital for not having properly treated the patient, be it in terms of malaria treatment or in terms of monitoring the fluids electrolytes, which would have prevented acute renal failure of the patient.

He further submitted before the NCDRC bench that the State Commission erred in relying upon an expert opinion of Doctors constituted by the NPCIL under whose overall control the hospital functioned. Then he submitted that when the condition was not improving after two days of treatment, the patient should have been referred to a super speciality hospital.

While considering the matter, the top consumer court observed, “Evidently and indisputably, the patient had malaria for which anti-malaria treatment was started by the hospital. It is also a fact that the anti-malarial drug causes vomiting and loose motion. Therefore, the first two to three days are not significant in a sense that the line of treatment was normal in the circumstance of the case and no negligence was shown by the doctors.”

However, the Commission noted that the situation changed after the third day when the patient’s condition was deteriorating very fast and the patient started developing secondary conditions which the hospital and its Doctors “either failed to notice or totally ignored the same.”

“It is also a fact that after two days of hospitalization, the Complainant requested the hospital authorities to refer the patient to BARC Hospital, Mumbai. It is also a fact that TAPS Hospital is more like a big dispensary and it does not have a Critical Care facility. While not taking such decision on second day by TAPS, is understandable, but thereafter, on going through the history and on the record, not taking such decision is an issue which needs to be looked into closely and in my opinion is critical in deciding this Complaint,” the NCDRC bench noted.

The Commission also perused the death summary report of Jaslok Hospital and Research Centre where the patient was admitted in the late evening of 16.07.1998 and was declared dead in the early hours of 17.07.1998. 

Relying on this report, the Commission observed, “The Jaslok report is significant because it has correctly noted in an impartial manner the sequence of events and thus more reliable. The significant observation has been that the Complainant was admitted in the hospital for five days with complaints of fever, chills and decreased output for three days. The third day would start definitely of 14/15.07.1998. When this has been noticed by the Doctor, from the hospital record, it is seen that they have totally ignored it and have continued with treatment for conditions other than this problem. I notice that on the one hand, IV fluid has been given and subsequently lasix has been given. These are the procedures to be adopted in a normal course. However, such procedure cannot be undertaken when it is observed that the urine output has either reduced or totally stopped on 15.07.1998.”

The Commission noted that the reduced urine output in a malarial situation was a clear indication of serious kidney problems. It opined that the “Hospital should have shown promptness for the patient to be referred to a Super Specialty Hospital for further treatment where facility of dialysis / ventilator in an appropriate Nephrology ICU would have been available.”

“Reduced output of urine is a sign of the patient having renal failure. Eventually when on 15.07.1998 the blood tests were conducted, it was found that the parameters indicating renal failures had already been on a very high side, including the level of creatinine and the reduction of platelets. Not having referred the patient even as late as 15.07.1998 was definitely a most negligent step taken by the Doctors and the Hospital as there would have been a possibility that if the patient had been put on a ventilatory support with dialysis, he would have recovered. It has to be borne in mind that the patient was very young and that he had no history of any disease whatsoever. Reduced urine output is a clear indication of a renal stress and should not have been allowed to have been handled by a hospital with limited facilities and no specialist Doctors,” the Commission further observed.

NCDRC noted that the problem of not diagnosing the seriousness of the reduction in urine output was further compounded by the fact that even when the patient was referred to BARC Hospital, Mumbai, it should have been known by the Doctors in TAPS Hospital, being a sister concern, that facility for treatment of renal failure does not exist in BARC Hospital.

Opining that there was a lack of concern on the part of the treating hospital, the Commission further noted,

“It would have been the primary responsibility of the Superintendent of the Hospital to have taken this minimum precaution and care to find out where should the patient be referred to after coming to know about the renal failure. This shows that the hospital authority did not exercise due care in referring the patient to the proper hospital. In case of renal failure, time becomes an essence and therefore, this shows the lack of concern on the part of the hospital authorities.”

The top consumer court opined that the State Commission had ignored these factors. It also expressed its shock over the report of the expert Committee, which was headed by a Chief Engineer, NPCIL.

“For reduced urine flow even a Doctor with a normal competence would have understood the gravity of the situation. Administration of Lasix and IV fluid is not a solution when urine output is getting progressively reduced and creatinine level jumping. This should have been seen in the backdrop of the patient having the condition of malaria since last four days and who had not responded with all the multi malarial drugs and the drugs for reducing vomiting and loose motion including administration of powerful antibiotics,” noted the Commission.

“For not understanding this simple medical condition, in my opinion, is nothing short of serious medical negligence. It is not my contention that the Doctors should have given some other treatment, it is my contention that this hospital was just not equipped to handle such situation. The State Commission has missed the critical point. By the time the patient was referred to BARC Hospital on the evening of 16.07.1998, the patient had already crossed the stage of any recovery. The Expert Opinion of the Respondents is in my opinion, nothing more than covering up the mistake committed by TAPS hospital and its administration,” it further observed.

The Apex Consumer Court opined that it was collective negligence on the part of the hospital represented by its medical superintendent. The hospital was held responsible for medical negligence and for the death of the patient for not taking into cognizance the reduced urine output on the date on which it was first reported and for not referring the patient to a Super Specialty Hospital soon after it came to know of the reduced urine output in the circumstances of the case.

Accordingly, setting aside the State Commission’s order, the NCDRC bench ordered, “The Respondent No. 1 is directed to pay an amount of Rs. 16 lakhs along with interest @ 9% per annum from the date of death of the patient till realization to the Complainants within six weeks of this Order, failing which, the rate of interest shall be 12% per annum for the same period. Further, the Respondent No. 1 shall pay Rs. 1 lakh as cost of litigation to the Complainants within six weeks, failing which interest @ 9% per annum shall be paid from the date of this Order till realisation.”

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/ncdrc-order-239270.pdf

Also Read: Delay in treating patient with Obstructive Hydrocephalus: Consumer Court slaps compensation on Delhi Hospital, 2 Senior consultants for negligence

Powered by WPeMatico

ESIC Medical College Patna Invites applications for Associate Fellow of Industrial Health Course 2024, Apply Now

Patna- Employees’ State Insurance Corporation (ESIC) has invited applications for admission to the 1st batch of ‘Associate Fellow of Industrial Health (AFIH) Course for the academic year 2024.

On this, ESIC has released a prospectus detailing the important dates, eligibility, experience, application fees and other important information about the course.

IMPORTANT DATES AND DEADLINES

S.NO

PARTICULARS

DATES

1

Application start.

20.05.2024

2

Last Date to apply.

10.06.2024

3

Interview of shortlisted candidates through virtual Mode (if required) following e-mail communication/ intimation.

17.06.2024

4

Declaration of results (1st round) on ESIC website followed by e-mail communication.

19.06.2024

5

Submission of course fee and completion of admission formalities (1st round).

20.06.2024 – 21.06.2024

6

Publication of vacant seats (2nd round) & intimation to waitlisted candidates through e-mail.

22.06.2024

7

Submission of course fee by 2nd round candidates.

24.06.2024 – 25.06.2024

8

Vacancy Publication after 2nd round (Open round), if required.

26.06.2024

9

Open-round admission, if required.

27.06.2024

10

Course Commences.

01.07.2024 – 30.09.2024

ELIGIBILITY FOR ADMISSION

1. MBBS Degree from an Institution recognised by the National Medical Council of India/Medical Council of India.

2. Completion of Internship.

3. Permanent Registration with the National Medical Council of India/Medical Council of India/State Medical Council.

EXPERIENCE

As on the opening date of application i.e. 20 May 2024, after completion of the compulsory internship, the applicant should have a minimum of one year experience in the registered Factory, Mines, Dock Works, Construction Work and Plantation Work under the respective statutes.

Two years of working experience in hospitals including self-practice. The period spent on higher studies (full-time NMCI/MCI recognized Degree or Diploma Course only) after completion of MBBS Degree and internship with registration to Medical Council of India/State Medical Council shall be considered as equivalent to self-practice for fulfilling eligibility criteria for admission to AFIH Course, subject to production of valid certificates.

SUBMISSION OF APPLICATION

The prescribed application should be completed in all respects, together with self-attested photocopies of certificates and Demand Draft/ Banker’s Cheque of the requisite amount should be submitted by hand/post and a soft copy by e-mail in single PDF format on or before the 10th of June 2024.

Applicants working in Government or Public sector undertakings or Autonomous Bodies etc. should apply through proper channels only and if the applications are received from the candidates without the approval of the sponsoring authority, the same will be rejected.

Incomplete applications and applications received after the due date and time will not be considered for scrutiny and they will be summarily rejected. No correspondence in this regard will be entertained.

APPLICATION FEES

Application Fees: Rs. 500/- (Five Hundred Only) to be submitted while applying for admission which will be non-refundable.

The selected candidates shall have to pay Rs. 25000/- (Twenty-Five Thousand only) as Institute fee which will be non-refundable while joining the course.

The candidate will have to furnish a Demand Draft/ Bankers Cheque only for the requisite amount drawn in favour of ‘ESIC A/c No 2’ payable at Bihta, Patna, preferably from the State Bank of India.

LIST OF ENCLOSURES TO BE ATTACHED

1. Self-attested photocopy of-

a. MBBS Degree Certificate.

b. Internship Experience Certificate.

c. NMCI/MCI/State Medical Council Registration Certificate(s).

d. SC/ST/OBC/PH/EWS Certificate issued by the competent authority, if applicable.

e. Experience Certificate(s).

2. Sponsorship Certificate in original, in case of sponsored candidate only.

3. No Objection Certificate in original, in case if candidate is currently working in Government or Public sector undertakings or Autonomous Bodies.

4. If there is a change in the name of the applicant, a copy of the Gazette of India and Medical Council Registration with the changed name should be provided.

5. If the certificates given by the applicant are found to be false or forged or fabricated, the admission issued to the candidate will be cancelled immediately after the receipt of the inquiry report from a committee constituted by the AFIH Academic Council in this regard and such candidates will not be considered for admission at any point of time. Apart from the above, a complaint will also be filed in the nearest police station of the institute for initiating necessary action.

APPLICATION PROCEDURE

1 Competency-based course curriculum, guidelines including eligibility and admission process for the training program is attached below. Interested candidates shall apply in the prescribed application form along with self-attested copies of necessary documents through speed post.

2 On the outer envelope, it shall be written as: “APPLICATION FOR AFIH”.

3 Last date for receipt of the application form through speed post/ surface mail by/ before 10 June 2024.

4 No TA/DA etc will be provided to attend the document verification/admission/ Reporting/Open Round Counseling or for any other purpose.

5 Information related to admission/selection or any other matter for this training program will be notified/updated on the ESIC website from time to time. The admission process will end on 27 June 2024 by 16:00 Hrs.

INTERVIEW

The interview for the short-listed candidates will be held on 17th June, 2024 from 10:30 hrs onwards through online mode only if no. of applications exceeds 30 i.e. total no. of seats. In case of more than 30 applications, shortlisted candidates will be called for the interview on virtual mode.

To view the Prospectus, click the link below

Powered by WPeMatico

NPPA Fixes Ceiling price Of 6 Scheduled Formulations, Details

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the ceiling price of the 6 scheduled formulations under the Drugs (Prices Control) Order, 2013.

The list includes Ampicillin Powder for injection of 1000 mg, Cloxacillin Capsules of 500mg and 250mg, Oxaliplatin Injection 5 mg/mL in 20ml vial, Oral Rehydration Salts as licensed, 5-Amino Salicylic acid (Mesalazine / Mesalamine) 400mg.

Scheduled formulation are any formulation, included in the first schedule whether referred to by generic versions or brand name (mainly products covered under the National List of Essential Medicines are Scheduled Formulation). In other words, all medicines that are covered in the National List of Essential Medicine, which are notified in Schedule 1, by the Govt. are scheduled formulation.

“Ceiling Price” refers to a price fixed by the Government for Scheduled Formulations following the provisions of the drugs (price control) order, 2013. The ceiling Price is the Maximum Price to Retailer (excluding Taxes, if any) for the given product.

This came in exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No SO 1548(E) dated 26th March, 2024 in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority (NPPA) has fixed the price as specified in column (5) of the table herein below as ceiling price exclusive of goods and services tax applicable, if any, in respect of the Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

Sl.

No.

Medicines

Dosage form and strength

Unit

Ceiling Price (Rs.)

(1)

(2)

(3)

(4)

(5)

1

Ampicillin

Powder for injection 1000 mg

1 Vial

24.92

2

Cloxacillin

Capsule 500mg

1 Capsule

2.38

3

Cloxacillin

Capsule 250mg

1 Capsule

1.41

4

Oxaliplatin

Injection 5 mg/mL in 20ml vial

1 Vial

4979.68

5

Oral Rehydration Salts

As licensed

1 GM

0.99

6

5-Amino Salicylic acid (Mesalazine / Mesalamine)

Tablet 400mg

1 Tablet

7.92

The notification further added:

  • All manufacturers of scheduled formulation, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.
  • All the existing manufacturers of the above-mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.
  • The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.
  • The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
  • As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
  • Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2(1)(u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
  • The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule- II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
  • The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
  • Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued before the above said date of notification, stand(s) superseded.

Also Read:NPPA Fixes Retail Prices of 69 Formulations, Details

To view the official notice, click the link below:

Powered by WPeMatico

255 JR Post At RML Hospital Delhi: Check Out All Details Here

New Delhi: The Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital (ABVIMS & RML Hospital Delhi), has announced the vacancies for the post of Junior Resident (Non-Academic) on an regular basis in this medical institute. 

Dr Ram Manohar Lohia Hospital, formerly known as Willingdon Hospital, was established by the British for its staff and had only 54 beds. After independence, its control was shifted to New Delhi Municipal Committee. In 1954, its control was again transferred to the Central Government of Independent India.

RML Hospital Vacancy Details:

Total no of vacancies: 255

The last date for Submission of the Application is the 5th June 2024 till 3:00 p.m.

For more details about Qualifications, Age, Pay Allowance, and much more, click on the given link:
https://medicaljob.in/jobs.php?post_type=&job_tags=RML+Hospital&location=&job_sector=all

Eligible Candidates (How to Apply)?

1. Application should be submitted in Central Diary & Dispatch Section, Near Gate No. 3, ABVIMS & Dr. Ram Manohar Lohia Hospital, New Delhi-110001, latest by 05.06.2024 till 03:00 PM. The application send by post must be having written prominently on the top of the envelop “Application for the post of Junior Resident (Non-Academic). It is also informed that Hospital will not be responsible for any postal delay.

2. Prescribed Application form duly filled & signed (Annexure-l) should be accompanied with self altested copies of final year mark sheet of M.B.B.S pass certificale, DMC registration certificate, Internship completion certificate, Category clrtificate, 1Oth class pu..irg certificate and copy of Aadhar Card, pAN Card

3. Counseling will be done on the basis of merit in written examination for the allotment of seats in various departments.

4. The List of eligible applicants for the written examination will be uploaded on Hospital Website (www.rmlh.nic.in) only. After scrutiny the list of rejected applications will also be displayed on hospital website.

5. If it is found, that the applicant has suppressed any information or given wrong information his/her Junior Residency (Non – Academic) will be terminated forthwith without assigning any reason.

Note: It is informed that Dr. RML Hospital will not made individual communication to any candidate. All updates regarding list of eligible candidates, Admit Card, Result’ Counseling, Offer Letter etc will be uploaded on Dr. RML Hospital official Website (www.rmlh.nic.in) only. The applicants are advised to visit the website regularly for any updates.

Powered by WPeMatico

Army Hospital organizes Hands-On Fetal Invasive and Therapeutic Workshop

New Delhi: Lieutenant General Ajith Nilakantan, PVSM, Commandant of Army Hospital (Research and Referral), inaugurated a hands-on fetal invasive and therapeutic workshop conducted by the Maternal-Fetal Medicine subdivision of the Department of Obstetrics and Gynaecology on Friday.

The was attended by 70 civilian delegates and 15 officers of the Armed Forces Medical Services (AFMS), reports news agency ANI.

Also Read:AFMS, ICMR join hands for collaborative research and training

The event featured lectures and demonstrations of invasive procedures such as amniocentesis, chorionic villous sampling, cordocentesis, fetal reduction, and intrauterine transfusion. Following the lectures, participants received hands-on training using high-fidelity humanoid mannequins. 

Earlier in April this year, General Manoj Pande, the Chief of the Army Staff, inaugurated new enhanced facilities at Army Hospital (R&R). The COAS also unveiled the newly expanded Department of Physical Medicine and Rehabilitation (PMR) and Sports Medicine.

Army Hospital (R&R) is known to be a premier establishment as far as healthcare facilities in the armed forces are concerned.

Medical Dialogues team had earlier reported that in a spirited commemoration of World Health Day 2024, the College of Nursing at Army Hospital (Research and Referral) orchestrated a vibrant celebration under the theme “My Health, My Right.” The event, radiated enthusiasm as students fervently advocated for holistic well-being, delving into the realms of physical, mental, and spiritual health. The occasion not only served as a platform for raising awareness but also as an educational endeavor, with students passionately emphasizing the interconnectedness of various facets of health in fostering overall wellness. Additionally, a Nutrifest was also organised by the students to educate participants about various therapeutic diets and their role in maintaining health.  

Powered by WPeMatico

TN Teen Footballer Death Case: Disciplinary Committee recommends no action required for AP Orthopedics, CMO

Chennai: The doctors accused of the botched surgery of teen footballer R Priya in 2022 will not face any action from the state medical council disciplinary committee after the committee members took into consideration that the Directorate of Medical Education had already taken departmental actions such as suspension and transfer against them.  

The decision came after the Directorate of Medical Education informed the committee in April that the two doctors- AP Orthopedics and CMO accused of the botched surgery were suspended for medical negligence. Therefore, the committee told the State Medical Council no further action was required.

Meanwhile, the Madras High Court also refused to grant anticipatory bail to the doctors and medical staff in November 2022 as the issue was still in the initial phase and the probe was still incomplete. The expert committee of the Health Department held five persons including four doctors and one ward staff responsible for the incident leading to her death.

Further, the committee has submitted the recommendation to the ad-hoc committee of the state medical council for their ultimate decision.

Also read- No Bail For AP Orthopedics, CMO Over Death Of Teenage Footballer Due To Delay In Removal Of Tourniquet

The decision has deeply upset the family members of the late Priya, who have never stopped fighting for their daughter’s justice. The victim’s brother told TOI “We were not even aware of this inquiry. How did they conclude this without speaking to us? We filed a case against the doctors and staff, and an FIR was registered. But the case hasn’t moved forward. Since the govt gave our family a compensation of 10 lakh and a contract job as a data entry operator in the health department for me, the police feel the case can be closed. We told them our loss was bigger.”

Medical Dialogues team had earlier reported about the 17-year-old footballer, Priya R, who lost her life due to multi-organ failure following complications from an alleged botched arthroscopic surgery to fix a ligament at a government hospital in Tamil Nadu’s Chennai.

It was alleged that after her initial surgery at the Periyar Nagar Hospital on November 7, she began having pain in her legs. She was then prescribed a tight compression bandage and medicines for the pain. Over a suspected blood clot in her legs, she was transferred to Rajiv Gandhi Government General Hospital, where the doctors stated that the tissues in her right leg were dead and recommended an amputation.

The girl’s right leg was amputated on November 9, but her condition worsened following which a follow-up surgery was performed on her on Monday. However, she did not respond well to the treatment and later she passed away due to complications in her liver, heart and kidney.

Also read- Delay In Removal Of Tourniquet Leads To Death Of 17-Year-Old Footballer: AP Orthopedics, CMO Suspended For Negligence

Powered by WPeMatico

Louisiana votes to make abortion pills controlled substances

Louisiana has become the first state to pass a law that designates abortion pills as dangerous controlled substances.

Powered by WPeMatico

What to look for in mosquito repellents

There’s an old joke that mosquitoes are like family: They are annoying, but they carry your blood.

Powered by WPeMatico

Tips to prevent injuries while biking

Bicycling is a great way to stay active and enjoy the outdoors. Whether you’re a recreational rider or a daily commuter, it’s important to protect your hands and wrists. Dr. Sanj Kakar, a Mayo Clinic orthopedic surgeon specializing in hands and wrists, shares practical tips to prevent injuries while biking.

Powered by WPeMatico

Women’s heart risk spikes after menopause, study shows

At first, no one thought Nina White had a heart attack. Every detail of that day 10 years ago, when she was just 51, is sharp in her memory. She thought the tightness in her chest was overexertion from multiple trips up the ladder to the attic in her Portsmouth, Virginia, home. Her husband thought it was indigestion from tacos.

Powered by WPeMatico